This compound is a protected amino acid derivative containing an Fmoc group and a dichloroethenyl-sulfonyl-modified aromatic ring. The steric and electronic features support incorporation into specialized peptidomimetics. Researchers employ it to study reactivity, coupling efficiency, and structural constraints. Its custom side chain enables design of rigid or electrophilic peptide frameworks.
CAT No: 10-101-286
CAS No:1151854-06-6
Synonyms/Alias:FMOC-L-TYR(SO3DCV)-OH;1151854-06-6;MFCD26408195;E70910;(2S)-3-[4-(([(2,2-Dichloroethenyl)oxy]sulfonyl)oxy)phenyl]-fmoc-2-aminopropanoic acid;(2S)-3-[4-(2,2-dichloroethenoxysulfonyloxy)phenyl]-2-(9H-fluoren-9-ylmethoxycarbonylamino)propanoic acid;
2. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
3. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
5. The spatiotemporal control of signalling and trafficking of the GLP-1R
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.